title: Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.
authors.forename: Federico
authors.initials: F
authors.lastname: Perez
authors.forename: Rafael
authors.initials: R
authors.lastname: Ponce-Terashima
authors.forename: Mark D
authors.initials: MD
authors.lastname: Adams
authors.forename: Robert A
authors.initials: RA
authors.lastname: Bonomo
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000472:pathogenicity; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003428:Cross Infection / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents